Showing results (91-100 of 212) with videos related to
Sort By:
Pageof 22
Brain Research. Brain Research Protocols|May 10, 2005
A brightness-area-product-based protocol for the quantitative assessment of antigen abundance in fluorescent immunohistochemistryPaul D Smith, Karen J McLean, Michael A Murphy, et al.Contemporary Clinical Trials Communications|February 2, 2019
Design and rationale of a mixed methods randomized control trial: ADdressing Health literacy, bEliefs, adheRence and self-Efficacy (ADHERE) program to improve diabetes outcomesOlayinka O Shiyanbola, Denise L Walbrandt Pigarelli, Elizabeth J Unni, et al.Neurosurgery|March 28, 2022
Multiple Meningiomas as a Criterion for the Diagnosis of Neurofibromatosis Type 2 and Other Tumor Predisposition SyndromesCathal John Hannan, Charlotte Hammerbeck-Ward, Omar Nathan Pathmanaban, et al.Cancer Research|August 5, 2008
BRAF V600E disrupts AZD6244-induced abrogation of negative feedback pathways between extracellular signal-regulated kinase and Raf proteinsBret B Friday, Chunrong Yu, Grace K Dy, et al.Neurology|November 19, 2016
Revisiting neurofibromatosis type 2 diagnostic criteria to exclude LZTR1-related schwannomatosisMiriam J Smith, Naomi L Bowers, Michael Bulman, et al.BMJ Health & Care Informatics|October 21, 2019
Using normalisation process theory to understand workflow implications of decision support implementation across diverse primary care settingsRebecca G Mishuris, Joseph Palmisano, Lauren McCullagh, et al.Annals of Plastic Surgery|March 23, 2017
Complications and Recurrence in Implant-Sparing Oncologic Breast SurgeryJoshua B Elston, Sangeetha Prabhakaran, Amina Lleshi, et al.Cancer Research Communications|March 27, 2023
Pharmaceutical Reactivation of Attenuated Apoptotic Pathways Leads to Elimination of Osimertinib Drug-Tolerant CellsMatthew J Martin, Nicolas Floc'h, Matthias Pfeifer, et al.Neurosurgery|October 4, 2017
High-Grade Glioma is not a Feature of Neurofibromatosis Type 2 in the Unirradiated PatientAndrew T King, Scott A Rutherford, Charlotte Hammerbeck-Ward, et al.Patient Preference and Adherence|March 18, 2022
Feasibility of a Randomized Controlled Mixed Methods Trial to Address Health Literacy, Beliefs, Medication Adherence, and Self-Efficacy (ADHERE) in a Clinical Pharmacist-Led ClinicOlayinka O Shiyanbola, Martha A Maurer, Natasha Virrueta, et al.Pageof 22